Insmed Inc
NASDAQ:INSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insmed Inc
NASDAQ:INSM
|
US |
|
APL Apollo Tubes Ltd
NSE:APLAPOLLO
|
IN |
|
B3 Consulting Group AB (publ)
STO:B3
|
SE |
|
Soditech SA
PAR:SEC
|
FR |
|
G
|
Great-West Lifeco Inc
F:GWS
|
CA |
|
Thalassa Holdings Ltd
LSE:THAL
|
VG |
|
ONE Gas Inc
NYSE:OGS
|
US |
|
BKW AG
LSE:0QQ0
|
CH |
|
Sasol Ltd
NYSE:SSL
|
ZA |
|
Verallia SA
PAR:VRLA
|
FR |
|
Orix Corp
NYSE:IX
|
JP |
|
Canoo Inc
NASDAQ:GOEV
|
US |
|
I
|
IMAX China Holding Inc
SWB:IMK
|
CN |
|
Shiseido Co Ltd
F:SHDA
|
JP |
|
S
|
Socovesa SA
SGO:SOCOVESA
|
CL |
|
CarGurus Inc
NASDAQ:CARG
|
US |
|
Diageo PLC
LSE:DGE
|
UK |
|
B
|
Bunge Ltd
BMV:BG
|
US |
|
S
|
Salvatore Ferragamo SpA
XBER:S9L
|
IT |
|
Inghams Group Ltd
ASX:ING
|
AU |
Wall St Price Targets
INSM Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for
INSM is 209.02 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INSM's stock price target?
Price Target
209.02
USD
According to Wall Street analysts, the average 1-year price target for
INSM is 209.02 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.
What is the Revenue forecast for Insmed Inc?
Projected CAGR
44%
The compound annual growth rate for Revenue over the next 8 years is 44%.